Black Diamond Therapeutics Inc (BDTX) Insider Trading
- $109,673,640.52
- $9,995,462.12
- Oct. 17, 2023
- Bradley J Phd Bolzon
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 17, 2023 | Major Shareholder | 400,000 | $2.34 | Buy | $936,000.00 | |
July 5, 2023 | Director | 1,000,000 | $5.00 | Buy | $5,000,000.00 | |
June 30, 2023 | Major Shareholder | 1,000,000 | $5.00 | Buy | $5,000,000.00 | |
June 27, 2023 | Major Shareholder | 1,740,000 | $5.49 | Buy | $9,552,600.00 | |
June 27, 2023 | Insider | 25,000 | $6.70 | Sell | $167,500.00 | |
Oct. 27, 2022 | Major Shareholder | 191,678 | $1.87 | Buy | $358,437.86 | |
Oct. 21, 2022 | Major Shareholder | 87,850 | $1.51 | Buy | $132,653.50 | |
Oct. 19, 2022 | Major Shareholder | 77,689 | $1.32 | Buy | $102,549.48 | |
June 29, 2022 | Insider | 25,000 | $2.44 | Buy | $61,000.00 | |
April 27, 2022 | Major Shareholder | 150,000 | $2.66 | Buy | $399,000.00 | |
April 18, 2022 | Major Shareholder | 150,000 | $3.29 | Buy | $493,500.00 | |
April 12, 2022 | Major Shareholder | 150,000 | $3.42 | Buy | $513,000.00 | |
May 12, 2021 | Insider | 4,078 | $27.42 | Sell | $111,818.76 | |
May 3, 2021 | Insider | 2,500 | $26.64 | Sell | $66,600.00 | |
April 12, 2021 | Insider | 4,078 | $25.00 | Sell | $101,950.00 | |
April 5, 2021 | Insider | 2,500 | $25.54 | Sell | $63,850.00 | |
March 3, 2021 | Insider | 2,500 | $26.10 | Sell | $65,250.00 | |
Feb. 12, 2021 | Insider | 4,078 | $27.23 | Sell | $111,043.94 | |
Feb. 3, 2021 | Insider | 2,500 | $25.35 | Sell | $63,375.00 | |
Jan. 12, 2021 | Insider | 11,578 | $34.03 | Sell | $393,999.34 | |
Jan. 8, 2021 | CFO | 3,000 | $33.94 | Sell | $101,820.00 | |
Jan. 4, 2021 | Insider | 2,500 | $31.41 | Sell | $78,525.00 | |
Dec. 14, 2020 | Insider | 4,078 | $34.95 | Sell | $142,526.10 | |
Dec. 8, 2020 | CFO | 3,000 | $33.78 | Sell | $101,340.00 | |
Dec. 3, 2020 | Insider | 2,500 | $32.42 | Sell | $81,050.00 | |
Dec. 1, 2020 | Insider | 12,000 | $32.71 | Sell | $392,520.00 | |
Nov. 30, 2020 | Director | 10,393 | $33.15 | Sell | $344,527.95 | |
Nov. 18, 2020 | Major Shareholder | 473 | $33.09 | Sell | $15,651.57 | |
Nov. 18, 2020 | Director | 536 | $33.09 | Sell | $17,736.24 | |
Nov. 16, 2020 | Major Shareholder | 177 | $33.01 | Sell | $5,842.77 | |
Nov. 16, 2020 | Director | 200 | $33.01 | Sell | $6,602.00 | |
Nov. 12, 2020 | Director | 15,598 | $34.15 | Sell | $532,671.70 | |
Nov. 12, 2020 | Major Shareholder | 13,779 | $34.15 | Sell | $470,552.85 | |
Nov. 9, 2020 | Director | 6,300 | $33.06 | Sell | $208,278.00 | |
Nov. 9, 2020 | CFO | 3,000 | $32.96 | Sell | $98,880.00 | |
Nov. 9, 2020 | Major Shareholder | 5,565 | $33.06 | Sell | $183,978.90 | |
Nov. 6, 2020 | Major Shareholder | 2,738 | $33.13 | Sell | $90,709.94 | |
Nov. 6, 2020 | Director | 3,100 | $33.13 | Sell | $102,703.00 | |
Nov. 4, 2020 | Major Shareholder | 2,208 | $33.14 | Sell | $73,173.12 | |
Nov. 4, 2020 | Director | 2,500 | $33.14 | Sell | $82,850.00 | |
Nov. 2, 2020 | Insider | 12,000 | $31.14 | Sell | $373,680.00 | |
Oct. 26, 2020 | Major Shareholder | 7,158 | $33.30 | Sell | $238,361.40 | |
Oct. 26, 2020 | Director | 8,103 | $33.30 | Sell | $269,829.90 | |
Oct. 19, 2020 | Director | 4,233 | $33.43 | Sell | $141,509.19 | |
Oct. 19, 2020 | Major Shareholder | 3,739 | $33.43 | Sell | $124,994.77 | |
Oct. 16, 2020 | Director | 8,713 | $33.57 | Sell | $292,495.41 | |
Oct. 16, 2020 | Major Shareholder | 7,697 | $33.57 | Sell | $258,388.29 | |
Oct. 14, 2020 | Director | 5,501 | $33.09 | Sell | $182,028.09 | |
Oct. 14, 2020 | Major Shareholder | 4,859 | $33.09 | Sell | $160,784.31 | |
Oct. 12, 2020 | Major Shareholder | 353 | $33.11 | Sell | $11,687.83 |
Insiders are both buying and selling Black Diamond Therapeutics Inc stock.
The insider traders at Black Diamond Therapeutics Inc are: Versant Venture Capital Vi, L., Bradley J Phd Bolzon, Growth N V Biotech, Christopher D Roberts, Brent Hatzis-Schoch, Thomas Leggett, David M Epstein, James E Flynn, Fang Ni, Robert Alexander Ingram, Rajeev M Shah, and Ali Behbahani
The most active insider trader at Black Diamond Therapeutics Inc is Versant Venture Capital Vi, L. with 15 trades.
Bradley J Phd Bolzon has sold the most Black Diamond Therapeutics Inc stock with a total value of $3,962,771.26.
Rajeev M Shah has bought the most Black Diamond Therapeutics Inc stock with a total value of $75,760,000.00.
The most recent insider trade for Black Diamond Therapeutics Inc was on Oct. 17, 2023.
The single biggest insider buy for Black Diamond Therapeutics Inc was from Rajeev M Shah with a total value of $37,880,000.00 on Feb. 3, 2020.
The single biggest insider sell for Black Diamond Therapeutics Inc was from Bradley J Phd Bolzon with a total value of $616,684.75 on Oct. 8, 2020.